Tactic Pharma, CEO: Monopar Therapeutics MNPR Sell · Filed 25/09/26

Trade details

Type: Insider sale
Amount: $35,000,066.69
Shares · price: 550,229 sh · $63.61 a share
Held after: 272,026 sh
Stock: Monopar Therapeutics MNPR
Person: Tactic PharmaCEO
Trade date: 25/09/24
Filed: 25/09/26
Days to filing: 2 days

Sold 66.9% of holdings

Share of holding sold: 66.9%

Monopar Therapeutics trades, last 26 weeks

What else happened in Monopar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/25~25/10/24

Tactic Pharma's recent trades

Tactic PharmaCEO
SellMonopar Therapeutics
Sell
Monopar Therapeutics
MNPR
$1.2M
33,334 sh
$1.2M
Filed 25/04/04
Traded 25/04/02
Tactic Pharma10% Stockholder
Planned saleMonopar Therapeutics
Planned sale
Monopar Therapeutics
MNPR
$1.2M
33,334 sh
$1.2M
Filed 25/04/02
Traded 25/04/02